1. Home
  2. OMH vs XLO Comparison

OMH vs XLO Comparison

Compare OMH & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • XLO
  • Stock Information
  • Founded
  • OMH 2015
  • XLO 2016
  • Country
  • OMH Singapore
  • XLO United States
  • Employees
  • OMH N/A
  • XLO N/A
  • Industry
  • OMH Real Estate
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMH Finance
  • XLO Health Care
  • Exchange
  • OMH Nasdaq
  • XLO Nasdaq
  • Market Cap
  • OMH 35.8M
  • XLO 35.7M
  • IPO Year
  • OMH 2023
  • XLO 2021
  • Fundamental
  • Price
  • OMH $1.27
  • XLO $0.82
  • Analyst Decision
  • OMH Hold
  • XLO Buy
  • Analyst Count
  • OMH 1
  • XLO 2
  • Target Price
  • OMH N/A
  • XLO $3.00
  • AVG Volume (30 Days)
  • OMH 284.7K
  • XLO 453.9K
  • Earning Date
  • OMH 09-25-2025
  • XLO 11-06-2025
  • Dividend Yield
  • OMH N/A
  • XLO N/A
  • EPS Growth
  • OMH N/A
  • XLO N/A
  • EPS
  • OMH N/A
  • XLO N/A
  • Revenue
  • OMH $7,976,578.00
  • XLO $15,001,000.00
  • Revenue This Year
  • OMH $28.40
  • XLO $519.70
  • Revenue Next Year
  • OMH $23.07
  • XLO $44.57
  • P/E Ratio
  • OMH N/A
  • XLO N/A
  • Revenue Growth
  • OMH 117.53
  • XLO 536.45
  • 52 Week Low
  • OMH $0.59
  • XLO $0.62
  • 52 Week High
  • OMH $5.10
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • OMH 51.16
  • XLO 63.99
  • Support Level
  • OMH $1.24
  • XLO $0.79
  • Resistance Level
  • OMH $1.37
  • XLO $0.91
  • Average True Range (ATR)
  • OMH 0.08
  • XLO 0.04
  • MACD
  • OMH -0.00
  • XLO 0.00
  • Stochastic Oscillator
  • OMH 47.57
  • XLO 54.12

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: